European attitudes to gene therapy and pharmacogenetics

John Hudson, Marta Orviska

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Views on pharmacogenetics and gene therapy systematically differ across European countries. But despite a complex regulatory regime there is a balance of support, albeit laced with considerable uncertainty.
Original languageEnglish
Pages (from-to)843-847
Number of pages5
JournalDrug Discovery Today
Volume16
Issue number19-20
DOIs
Publication statusPublished - 2011

Fingerprint

Pharmacogenetics
Genetic Therapy
Uncertainty

Cite this

European attitudes to gene therapy and pharmacogenetics. / Hudson, John; Orviska, Marta.

In: Drug Discovery Today, Vol. 16, No. 19-20, 2011, p. 843-847.

Research output: Contribution to journalArticle

Hudson, John ; Orviska, Marta. / European attitudes to gene therapy and pharmacogenetics. In: Drug Discovery Today. 2011 ; Vol. 16, No. 19-20. pp. 843-847.
@article{408abc44208c4ab3b9e0ae23eccb7f97,
title = "European attitudes to gene therapy and pharmacogenetics",
abstract = "Views on pharmacogenetics and gene therapy systematically differ across European countries. But despite a complex regulatory regime there is a balance of support, albeit laced with considerable uncertainty.",
author = "John Hudson and Marta Orviska",
year = "2011",
doi = "10.1016/j.drudis.2011.06.008",
language = "English",
volume = "16",
pages = "843--847",
journal = "Drug Discovery Today",
issn = "1359-6446",
publisher = "Elsevier",
number = "19-20",

}

TY - JOUR

T1 - European attitudes to gene therapy and pharmacogenetics

AU - Hudson, John

AU - Orviska, Marta

PY - 2011

Y1 - 2011

N2 - Views on pharmacogenetics and gene therapy systematically differ across European countries. But despite a complex regulatory regime there is a balance of support, albeit laced with considerable uncertainty.

AB - Views on pharmacogenetics and gene therapy systematically differ across European countries. But despite a complex regulatory regime there is a balance of support, albeit laced with considerable uncertainty.

UR - http://www.scopus.com/inward/record.url?scp=80053935845&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1016/j.drudis.2011.06.008

U2 - 10.1016/j.drudis.2011.06.008

DO - 10.1016/j.drudis.2011.06.008

M3 - Article

VL - 16

SP - 843

EP - 847

JO - Drug Discovery Today

JF - Drug Discovery Today

SN - 1359-6446

IS - 19-20

ER -